ITANISTOMIG
UNII ZCV7SK2URC

Substance Identification & Data

This profile provides standardized clinical and technical data for Itanistomig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZCV7SK2URC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923687-56-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZCV7SK2URC

CAS Registry Number

2923687-56-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ITANISTOMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C200549

National Cancer Institute reference terminology for clinical and research data.

INN ID

13139

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

Itanistomig

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Itanistomig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Itanistomig

Common Names & Synonyms

Fused heavy chain (VH anti-CD274 -G1CH1-h)-H-gamma1 anti-CD47 (1-683) [(VH-G1CH1-h) chain anti-CD274, Homo sapiens (1-226) [(VH (Homo sapiens IGHV1-69*01 (93.9%) -(IGHD) -IGHJ6*01 (93.8%), CDR-IMGT [8.8.16] (26-33.51-58.97-112)) (1-123) -Homo sapiens IGHG1*01 CH1-h, G1m17,1CH1 K120 (CH1 K120 (220) (124-221), hinge 1-5 (222-226) (124-226))] -11-mer (GPAPELLtrisglycyl-seryl) linker (227-237) -H-gamma1 anti-CD47, humanized (238-683) [VH (Homo sapiens IGHV5-51*01 (89.8%) -IGHD -IGHJ1*01 (100%), CDR-IMGT [8.8.9] (263-270.288-295.334-342)) (238-353)-Homo sapiens IGHG1*01 (100%), G1m17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (450) (354-451), hinge 1-15 (452-466), CH2 (467-576), CH3 D12 (592), L14 (594) (577-681), CHS (682-683)) (354-683)]], dimer (226-213':456-443')-bisdisulfide with fused light chain L-kappa anti-CD274-Lkappa anti-CD47 (1'-443') [L-kappa anti-CD274, Homo sapiens (1'-213') [VKAPPA (Homo sapiens IGKV3-11*01 (100%) -IGKJ1*01 (100%), CDRIMGT [6.3.8] (27'-32'.50'-52'.89'-96')) (1'-106') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (152'), V101 (190')) (107'-213')] -11-mer (GPAPLGL-trisglycyl-seryl) linker (214'-224') -L-kappa anti-CD47, humanized (225'-443') [V-KAPPA (Homo sapiens IGKV2-28*01 (92.0%) -IGKJ4*01 (100%), CDR-IMGT [11.3.9] (251'-261'.279'-281'.318'-326')) (225'-336') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (382'), V101 (420')) (337'-443')]]; dimer (462-462'':465-465'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

Immunoglobulin (VH-G1CH1-h)-H-gamma1_L-kappa-L-kappa, anti-[Homo sapiens CD274 (programmed cell death 1 ligand 1, PDL1, PD-L1, B7 homolog 1, B7H1, B7-H1, PDCD1LG1)] and anti-[Homo sapiens CD47 (CD47 molecule, integrin associated protein, IAP, MER6, OA3)], Homo sapiens and humanized monoclonal antibody, bispecific, tetravalent

itanistomig [INN]

External Clinical & Regulatory Resources

Previous UNIIZCT97MC8E4

Next UNIIZCX2XEC535